Doximity Stock Performance
| DOCS Stock | USD 24.59 0.22 0.90% |
The company owns a Beta (Systematic Risk) of 0.0608, which conveys relatively modest fluctuations relative to the market. With a sub-1 beta, Doximity participates in market rallies at a reduced pace while also limiting downside exposure. At this point, Doximity has a negative expected return of -0.89%. Please make sure to confirm Doximity's relationship between the Daily Balance Of Power and period momentum indicator, to decide if Doximity's performance from the past will be repeated in the future.
Risk-Adjusted Performance
Weak
Weak | Strong |
Over the last 90 days, Doximity generated negative risk-adjusted returns and added little value for investors with long positions. This reading is usually reviewed beside volatility, downside risk, and benchmark-relative behavior before conviction is increased. In spite of weak performance in the last few months, the stock's fundamental indicators remain comparatively stable, which may send shares a bit higher in April 2026. The newest uproar may also be a sign of mid-term up-swing for the firm's private investors. Learn More
Actual Historical Performance (%)
One Day Return 0.92 | Five Day Return -1.48 | Year To Date Return -43.20 | Ten Year Return -53.60 | All Time Return -53.60 |
1 | Doximity Upgraded to Strong-Buy at Zacks Research | 01/28/2026 |
2 | Insider Trading | 02/03/2026 |
3 | Doximity Q 3 Earnings and Revenues Surpass Estimates | 02/05/2026 |
4 | William Blair Dumps 21 Million of Healthcare Platform Doximity Stock | 02/09/2026 |
5 | Disposition of 8243 shares by Jeffrey Tangney of Doximity at 25.02 subject to Rule 16 b-3 | 02/13/2026 |
6 | Down Over 30 percent This Year Analysts Double Down on These 3 Beaten-Down Stocks | 02/20/2026 |
7 | Got 50,000 This Unbelievable Saa S Compounder Is Hiding in Plain Sight. | 02/23/2026 |
8 | Penfund Announces US 205 million Investment in DOCS Dermatology | 03/04/2026 |
9 | Assessing Doximity Valuation As Positive Analyst Sentiment Builds Around Its Telehealth Platform | 03/05/2026 |
10 | Disposition of 5000 shares by Benjamin Regina M. of Doximity subject to Rule 16 b-3 | 03/09/2026 |
11 | DOCS Dermatology Group Secures Refinancing and Upsizing from Penfund, Antares and New Mountain Appoints President and CFO to Support Growth Expansion | 03/10/2026 |
12 | Capital Fund Management S.A. Has 11.13 Million Stake in Doximity, Inc. DOCS | 03/13/2026 |
| Begin Period Cash Flow | 96.8 M | |
| Total Cashflows From Investing Activities | -29.3 M |
Doximity | Build portfolio with Doximity Stock |
Relative Risk vs. Return Landscape
If you had invested $ 4,371 in Doximity on December 17, 2025 and sold it today you would have lost $ 1,912 from holding Doximity or given up 43.74% of portfolio value over 90 days. Doximity does not currently generate positive expected returns and carries 3.4216% risk (volatility on return distribution) over a 90-day horizon. In different words, 30% of stocks are less volatile than Doximity, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Target Price Odds to finish over Current Price
A fundamental principle of stock forecasting is that prices tend to revert toward historical averages. For Doximity Stock, this mean-reverting tendency has been a useful tool for valuation. Still, some stocks exhibit persistent mispricings that are only corrected when buying and selling pressure realign.
| Current Price | Horizon | Target Price | Odds moving above the current price in 90 days |
| 24.59 | 90 days | 24.59 | about 89.69 |
According to our probability model, the chance of Doximity moving above the current price in 90 days from now is about 89.69 (This probability chart for Doximity depicts the range of likely prices for Doximity Stock over a 90-day horizon).
Doximity Price Density |
| Price |
Predictive Modules for Doximity
Predicting the direction of Doximity and the broader stock market involves a range of quantitative and qualitative techniques. Although accurate forecasting remains elusive, the process of modeling future scenarios is a valuable part of investment decision-making. Comparing results from different methods helps investors gauge the confidence level of their predictions.The concept of mean reversion suggests that Doximity's price will eventually return toward its long-run average. High prices may deter value investors, while unusually low prices often attract buyers who anticipate a recovery.
Primary Risk Indicators
Market volatility over the last 10-20 years has created both risk and opportunity for stock investors. Doximity has seen its share of dramatic price swings during this period. Implementing a hedging strategy and tracking Doximity's volatility and elasticity can help investors in Doximity limit the impact of adverse market moves.α | Alpha over Dow Jones | -0.8682 | |
β | Beta against Dow Jones | 0.06 | |
σ | Overall volatility | 8.59 | |
Ir | Information ratio | -0.2567 |
Investor Alerts and Insights
Real-time alerts for Doximity allow investors to track important stock developments as they happen. Reviewing ongoing notifications for Doximity helps identify opportunities and risks before they are fully priced into the market.| Doximity generated a negative expected return over the last 90 days | |
| Doximity has high historical volatility and very poor performance | |
| Over 93.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from MacroaxisInsider: Acquisition by Samuel Hazen of 1045 shares of HCA Holdings at 498.35 subject to Rule 16 b-3 |
Price Density Drivers
Market volatility will typically increase when uncertainty rises among traders holding long positions. The future price of Doximity Stock depends not only on investor outlook but also on the dynamics between participants with different trading approaches. Because risk indicators may produce small false signals, reviewing multiple metrics is recommended. Doximity's short-sentiment indicators are summarized below.
| Common Stock Shares Outstanding | 201.2 M | |
| Cash And Short Term Investments | 915.7 M |
Doximity Fundamentals Growth
Investors assess Doximity Stock by examining Doximity's underlying financial health. Revenue trajectory, earnings quality, profit margins, and leverage levels are among the most closely watched fundamentals that shape Doximity Stock market performance.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.38 % | |||
| Operating Margin | 0.39 % | |||
| Current Valuation | 3.78 B | |||
| Shares Outstanding | 133.81 M | |||
| Price To Earning | 67.68 X | |||
| Price To Book | 4.60 X | |||
| Price To Sales | 7.19 X | |||
| Revenue | 570.4 M | |||
| Gross Profit | 572.39 M | |||
| EBITDA | 240.76 M | |||
| Net Income | 223.19 M | |||
| Cash And Equivalents | 776.25 M | |||
| Cash Per Share | 4.01 X | |||
| Total Debt | 12.4 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 7.24 X | |||
| Book Value Per Share | 5.29 X | |||
| Cash Flow From Operations | 273.26 M | |||
| Earnings Per Share | 1.19 X | |||
| Market Capitalization | 4.59 B | |||
| Total Asset | 1.26 B | |||
| Retained Earnings | 186.89 M | |||
| Working Capital | 932.36 M | |||
Performance Metrics & Calculation Methodology
Doximity performance is measured on a risk-adjusted basis against benchmarks. Relative performance helps interpret behavior versus benchmarks or category peers. Doximity shows ROE of 23.82%, ROA of 12.84%.
For Doximity, this section uses periodic company reporting and market reference feeds with Macroaxis normalization rules applied to keep cross-asset comparisons consistent. Analyst inputs may be included when coverage is available. Intraday timing differences may exist. Return and risk statistics are calculated from historical price series.